(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

B2S CONSULTING

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

B2S CONSULTING

ST13

US500000085251151

Class

42

Filing

85251151

Registration

4090014

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

02/10/2023

Trademark type

Word

Nice classes

42

Filing date

02/24/2011

Registration date

01/24/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/10/2023

Last transaction

02/10/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

2002-06-00

First use in commerce

2002-06-00

Drawing code

4

Owner type

16

Owner location

FRANKLIN, IN

Examiner

BLANDU, FLORENTINA

Law office

M80

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

B2S LIFE SCIENCES LLC
Bowsher Brunelle Smith, LLC

Representatives

Jennifer L. Day BOSE MCKINNEY & EVANS LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Drug developmentanalytics and statistical consulting services for the biotechnology and pharmaceutical industriesscientific analytical research in the fields of biological sciencespharmaceutical researchbiotechnology; preclinical and clinical drug development support servicesconsultative services and data analysis in relation to quality control for others; conducting preclinical medical and scientific research and clinical trials; research and development for pharmaceutical drugs and biotherapeutics preparations for medical purposesall in the pharmaceutical and biopharmaceutical fields

Publications

History of USPTO decisions and trademark events.

52 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/10/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/10/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/10/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/09/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

07/25/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/24/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

05/08/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/08/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/04/2017

E815

TEAS SECTION 8 & 15 RECEIVED

03/16/2017

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/15/2017

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/24/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

01/24/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/08/2011

PUBO

PUBLISHED FOR OPPOSITION

11/08/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/01/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/29/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

09/28/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/28/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

09/28/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/28/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/01/2011

GNRT

NON-FINAL ACTION E-MAILED

09/01/2011

CNRT

NON-FINAL ACTION WRITTEN

09/01/2011

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

08/29/2011

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

08/15/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/02/2011

ALIE

ASSIGNED TO LIE

08/01/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/28/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

07/28/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/28/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

07/28/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/28/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/25/2011

GNRT

NON-FINAL ACTION E-MAILED

07/25/2011

CNRT

NON-FINAL ACTION WRITTEN

07/25/2011

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/21/2011

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

07/18/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/07/2011

ALIE

ASSIGNED TO LIE

07/06/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/02/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

06/24/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/24/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

06/24/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/24/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/31/2011

GNRT

NON-FINAL ACTION E-MAILED

05/31/2011

CNRT

NON-FINAL ACTION WRITTEN

05/31/2011

DOCK

ASSIGNED TO EXAMINER

05/26/2011

MPMK

NOTICE OF PSEUDO MARK MAILED

03/02/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/01/2011

NWAP

NEW APPLICATION ENTERED

02/28/2011

Continuous trademark protection

Get notified about every new filing that threatens B2S CONSULTING or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.